Cong Fang

Title: Cong Fang - Innovator in Antibody Development

Introduction

Cong Fang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents to his name, his work focuses on innovative solutions for medical applications.

Latest Patents

Cong Fang's latest patents include the development of recombinant chicken IgY monoclonal antibodies and scFv antibodies raised against human thymidine kinase 1 expressed in mammalian cells. This patent discloses a method for creating a recombinant chicken IgY monoclonal antibody and a single-chain variable fragment (scFv) antibody. The light chain of the scFv antibody includes an amino acid sequence shown in SEQ ID NO: 1, while the heavy chain includes an amino acid sequence shown in SEQ ID NO: 2. Another significant patent involves the expression of a recombinant chicken IgY scFv antibody and monoclonal antibody raised against human thymidine kinase 1 in prokaryotic cells. This patent highlights the good immunoreactivity, high specificity, and sensitivity of the antibodies, making them easy to separate and purify.

Career Highlights

Cong Fang is currently associated with Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited, where he continues to advance his research in antibody development. His work has garnered attention for its potential applications in diagnostics and therapeutics.

Collaborations

Cong Fang collaborates with notable colleagues, including Zuosheng Li and Hu Chen, who contribute to his research endeavors.

Conclusion

Cong Fang's innovative work in the field of antibody development showcases his commitment to advancing biotechnology. His patents reflect a significant contribution to medical science, paving the way for future advancements in the field.